Cite
HARVARD Citation
Kim, G. et al. (2021). The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis. Therapeutic advances in respiratory disease. p. . [Online].